Skip to content
2000
Volume 22, Issue 6
  • ISSN: 1871-5265
  • E-ISSN: 2212-3989

Abstract

Background: Leishmaniasis, caused by the Leishmania parasite, is one of the most important tropical neglected diseases. The urgent search for effective, inexpensive, and preferably herbal anti-leishmanial agents, is needed. Objective: Curcumin is a natural polyphenolic compound derived from turmeric that is well known for its antioxidant, anti-inflammatory, anti-tumor, and anti-cancer activity. Methods: The present work evaluates the anti-leishmanial [Leishmania major] activity of curcumin. The infected PBMCs were treated with curcumin. The ROS level at 6, 12, 24 h and gene expression levels at 24, 48, and 72 h of PBMCs after treatment with curcumin were determined. Results: Based on the results, the curcumin concentrations of 268 μM [24 h] and 181.2 μM [72 h] were defined as IC50 against L. major promastigotes. Treatment of L. major infected-peripheral blood mononuclear cells [PBMCs] with IC50 concentrations of curcumin, depending on exposure time, significantly induced the reactive oxygen species [ROS] generation and increased the expression levels of interferongamma [IFN-γ], tumor necrosis factor-alpha [TNF-α], and nitric oxide synthase [iNOS] genes. Conclusion: These findings suggest the potential of curcumin against Leishmaniasis.

Loading

Article metrics loading...

/content/journals/iddt/10.2174/1871526522666220404083220
2022-09-01
2024-11-30
Loading full text...

Full text loading...

/content/journals/iddt/10.2174/1871526522666220404083220
Loading

  • Article Type:
    Research Article
Keyword(s): Curcumin; gene expression; interferon gamma; Leishmania major; PBMCs; tumor necrosis factor
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test